-
1
-
-
0002904243
-
Management of peripheral artery disease (PAD)
-
TransAtlantic Inter-society Consensus (TASC). Management of peripheral artery disease (PAD). J Vasc Surg 2000; 31(suppl 2):S1-S283.
-
(2000)
J Vasc Surg
, vol.31
, Issue.SUPPL. 2
-
-
-
2
-
-
0032537068
-
A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs
-
Ouriel K, Veith F, Susahara A, for the TOPAS Investigators. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med 1998; 338:1105-1111.
-
(1998)
N Engl J Med
, vol.338
, pp. 1105-1111
-
-
Ouriel, K.1
Veith, F.2
Susahara, A.3
-
3
-
-
0028073262
-
Results of a prospective, randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity - The STILE Trial
-
STILE Investigators. Results of a prospective, randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity - the STILE Trial. Ann Surg 1994; 220:251-268.
-
(1994)
Ann Surg
, vol.220
, pp. 251-268
-
-
-
4
-
-
0033695759
-
Combination reperfusion therapy with abciximab and reduced dose reteplase: Results from TIMI 14
-
Antman E, Gibson C, de Lemos J, et al, for the Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. Eur Heart J 2000; 21:1944-1953.
-
(2000)
Eur Heart J
, vol.21
, pp. 1944-1953
-
-
Antman, E.1
Gibson, C.2
De Lemos, J.3
-
5
-
-
0343798542
-
Trial of abciximab with and without low-dose reteplase for acute myocardial infarction
-
Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Circulation 2000; 1010:2788-2794.
-
(2000)
Circulation
, vol.1010
, pp. 2788-2794
-
-
-
6
-
-
0023864355
-
Thrombolysis in Myocardial Infarction (TIMI) trial - Phase 1: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
-
Rao A, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) trial - phase 1: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988; 11:1-11.
-
(1988)
J Am Coll Cardiol
, vol.11
, pp. 1-11
-
-
Rao, A.1
Pratt, C.2
Berke, A.3
-
7
-
-
0032705316
-
Platelet glycoprotein IIb/IIIa receptor antagonist used in conjunction with thrombolysis for peripheral arterial thrombosis
-
Tepe G, Schott U, Erley C, Albes J, Claussen C, Duda S. Platelet glycoprotein IIb/IIIa receptor antagonist used in conjunction with thrombolysis for peripheral arterial thrombosis. AJR Am J Roentgenol 1999; 172:1343-1346.
-
(1999)
AJR Am J Roentgenol
, vol.172
, pp. 1343-1346
-
-
Tepe, G.1
Schott, U.2
Erley, C.3
Albes, J.4
Claussen, C.5
Duda, S.6
-
8
-
-
0035186419
-
Peripheral artery occlusion: Treatment with abciximab plus urokinase versus with urokinase alone - A randomized pilot trial (the PROMPT study)
-
Duda S, Tepe G, Luz O, et al. Peripheral artery occlusion: treatment with abciximab plus urokinase versus with urokinase alone - a randomized pilot trial (the PROMPT study). Radiology 2001; 221:689-696.
-
(2001)
Radiology
, vol.221
, pp. 689-696
-
-
Duda, S.1
Tepe, G.2
Luz, O.3
-
9
-
-
0033740736
-
Short and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis
-
Schweizer J, Kirch W, Koch R, Muller A, Hellner G, Forkmann L. Short and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis. Angiology 2000; 51:913-923.
-
(2000)
Angiology
, vol.51
, pp. 913-923
-
-
Schweizer, J.1
Kirch, W.2
Koch, R.3
Muller, A.4
Hellner, G.5
Forkmann, L.6
-
10
-
-
0035975605
-
Coadministration of low-dose urokinase and abciximab in thrombolysis for lower limb ischemia: A safety study
-
Haumer M, Atteneder M, Ahmadi R, Schillinger M, Minar E. Coadministration of low-dose urokinase and abciximab in thrombolysis for lower limb ischemia: a safety study. Thromb Res 2001; 103(suppl):S143-S149.
-
(2001)
Thromb Res
, vol.103
, Issue.SUPPL.
-
-
Haumer, M.1
Atteneder, M.2
Ahmadi, R.3
Schillinger, M.4
Minar, E.5
-
11
-
-
0034062754
-
Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis
-
Ouriel K, Gray B, Clair D, Olin J. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol 2000; 11:295-298.
-
(2000)
J Vasc Interv Radiol
, vol.11
, pp. 295-298
-
-
Ouriel, K.1
Gray, B.2
Clair, D.3
Olin, J.4
-
12
-
-
0035379733
-
Thrombolysis for native arterial occlusions of the lower extremities: Clinical outcome and cost
-
Korn P, Khilnani N, Fellers J, et al. Thrombolysis for native arterial occlusions of the lower extremities: clinical outcome and cost. J Vasc Surg 2001; 33:1148-1157.
-
(2001)
J Vasc Surg
, vol.33
, pp. 1148-1157
-
-
Korn, P.1
Khilnani, N.2
Fellers, J.3
-
13
-
-
0035065887
-
Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: Results and complications
-
Swischuk J, Fox P, Young K, et al. Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications. J Vasc Interv Radiol 2001; 12:423-430.
-
(2001)
J Vasc Interv Radiol
, vol.12
, pp. 423-430
-
-
Swischuk, J.1
Fox, P.2
Young, K.3
|